| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 2e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 4e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |